|Mr. Andreas Martinussen||Chief Exec. Officer||1,16M||N/A||N/A|
|Ms. Jannike Nilsen||Legal Director||152,55k||N/A||N/A|
|Mr. Finn Oistein Nordam||Chief Financial Officer||N/A||N/A||N/A|
|Mr. Ole Halvor Svenkerud||Chief Operating Officer||N/A||N/A||N/A|
|Ms. Gunhild Melle||Interim Chief Accountant||N/A||N/A||N/A|
|Mr. Ole-Henrik Stensrud||Leader HR||N/A||N/A||N/A|
|Mr. Tom Andre Svenning- Gultvedt||C.D.O||N/A||N/A||N/A|
|Mr. Rune Schive Hognestad||Chief Exec. Officer of Western Norway||N/A||N/A||N/A|
|Mr. Kjetil Somhovd Hagen||Chief Accountant||N/A||N/A||N/A|
|Mr. Stian Sjolyst Malmin||Chief Financial Officer of Western Norway||N/A||N/A||N/A|
Solon Eiendom ASA acquires, develops, and sells residential real estate properties in Norway. The company was formerly known as Bionor Pharma ASA and changed its name to Solon Eiendom ASA. The company was founded in 2006 and is headquartered in Oslo, Norway.
Solon Eiendom ASAs ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.